Andon Placzek

Altos Labs 
Addiction, synaptic plasticity, neuronal excitability, nicotinic receptors, cellular rejuvenation
"Andon Placzek"
Mean distance: 14.92 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Placzek AN, Prisco GV, Khatiwada S, et al. (2016) eIF2α-mediated translational control regulates the persistence of cocaine-induced LTP in midbrain dopamine neurons. Elife. 5
Huang W, Placzek AN, Viana Di Prisco G, et al. (2016) Translational control by eIF2α phosphorylation regulates vulnerability to the synaptic and behavioral effects of cocaine. Elife. 5
Placzek AN, Molfese DL, Khatiwada S, et al. (2016) Translational control of nicotine-evoked synaptic potentiation in mice and neuronal responses in human smokers by eIF2α. Elife. 5
Zhang TA, Placzek AN, Dani JA. (2010) In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology. 59: 431-6
Placzek AN, Zhang TA, Dani JA. (2009) Age dependent nicotinic influences over dopamine neuron synaptic plasticity. Biochemical Pharmacology. 78: 686-92
Placzek AN, Zhang TA, Dani JA. (2009) Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacologica Sinica. 30: 752-60
Placzek AN, Dani JA. (2009) Synaptic plasticity within midbrain dopamine centers contributes to nicotine addiction. Nebraska Symposium On Motivation. Nebraska Symposium On Motivation. 55: 5-15
McKay BE, Placzek AN, Dani JA. (2007) Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochemical Pharmacology. 74: 1120-33
Lopez-Hernandez G, Placzek AN, Thinschmidt JS, et al. (2007) Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons. Neuropharmacology. 53: 134-44
Placzek AN, Grassi F, Meyer EM, et al. (2005) An alpha7 nicotinic acetylcholine receptor gain-of-function mutant that retains pharmacological fidelity. Molecular Pharmacology. 68: 1863-76
See more...